Natalizumab Completed Phase N/A Trials for Disseminated Sclerosis Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive CareNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01455220The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis